Myelofibrosis and pancytopenia in systemic lupus erythematosus.
A 13-year-old Saudi girl presented with severe clinical features of systemic lupus erythematosus of 3 months' duration. In addition to laboratory evidence of the disease, the patient was found to have pancytopenia and myelofibrosis. While pancytopenia was considerably improved by steroids, myelofibrosis was not reversed. The coexistence of myelofibrosis and pancytopenia in patients with systemic lupus erythematosus has been reported, but their possible causal relationship remains unresolved.
el Mouzan
M I
MI
Department of Pediatrics, University Al Khobar, Saudi Arabia.
Ahmad
M A
MA
al Fadel Saleh
M
M
al Sohaibani
M O
MO
al Gindan
Y M
YM
D000293:Adolescent; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D010198:Pancytopenia / Q000188:drug therapy / Q000209:etiology*; D011239:Prednisolone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000188:drug therapy / Q000209:etiology*
D011239:Prednisolone